Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | See Remarks | November 17, 2023 | November 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date November 17, 2023 · Filed November 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,405 |
Ending reported balance
After 2023-11-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-17 · Grant · Acquired 200 · Balance 26,646 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Row 2 · 2023-11-17 · Tax withholding · Disposed 241 · Balance 26,405 F2: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021.
F2: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 408 | $0.00 Strike: $76.81 | $0.00 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · derivative · entry 12 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 408 shares Expires 2022-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 408 | $0.00 Strike: $62.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · derivative · entry 11 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 408 shares Expires 2021-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 24, 2014 date of grant, until fully vested on October 24, 2017. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 12 | $89.64 | $1,075.68 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 10 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,993 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.50 to $89.6525, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 377 | $88.93 | $33,526.42 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 9 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,005 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.42 to $88.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,149 | $87.79 | $100,869.56 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 8 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,382 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.35 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,369 | $86.21 | $204,226.28 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 7 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,531 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.83 to $86.82, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 8,058 | $85.40 | $688,152.39 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 6 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,900 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,050 | $51.95 | $54,547.50 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,049 | $71.55 | $75,055.95 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,050 | $73.31 | $76,975.50 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 408 | $76.81 | $31,338.48 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 408 | $62.11 | $25,338.84 |
DisclosureSEC source: 0001209191-20-046465 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 744 | $0.00 Strike: $61.40 | $0.00 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · derivative · entry 6 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires 2021-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 28, 2014 date of grant until fully vested on April 28, 2017. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 744 | $0.00 Strike: $60.22 | $0.00 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · derivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires 2021-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,488 | $78.22 | $116,391.36 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,993 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,000 | $80.00 | $320,000.00 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,481 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 744 | $61.40 | $45,681.60 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 744 | $60.22 | $44,803.68 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:56 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 483 | $65.39 | $31,583.37 |
DisclosureSEC source: 0001209191-20-026919 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,993 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. F2 · balance_after: Includes 93 shares acquired under the Issuer's employee stock purchase plan in March 2020. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 744 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · derivative · entry 9 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 28, 2013 date of grant until fully vested on October 28, 2016. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $39.80 | $0.00 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · derivative · entry 8 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2020-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vested and became exercisable on the 5th day of each month following the August 5, 2013 date of grant until fully vested on August 5, 2016. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,792 | $0.00 Strike: $31.73 | $0.00 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · derivative · entry 7 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,792 shares Expires 2020-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the August 2, 2010 date of the grant until fully vested on August 2, 2014. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 829 | $83.64 | $69,337.56 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · nonDerivative · entry 6 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,383 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 21, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.37 to $83.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,830 | $82.56 | $316,204.80 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · nonDerivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,212 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 21, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.29 to $83.18, inclusive. The reporting person undertakes to provide to the Company any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 6,877 | $81.86 | $562,951.22 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · nonDerivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,042 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 21, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.28 to $82.27, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 744 | $46.50 | $34,596.00 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,000 | $39.80 | $39,800.00 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 9,792 | $31.73 | $310,700.16 |
DisclosureSEC source: 0001209191-20-008755 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:34 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 2,078 | $66.69 | $138,581.82 |
DisclosureSEC source: 0001209191-20-006374 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,383 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 22:54 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option Plan · Derivative | 1,000 | $0.00 Strike: $35.76 | $0.00 |
DisclosureSEC source: 0001209191-20-001334 · doc4.xml · derivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2020-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the January 28, 2013 date of grant until fully vested on January 28, 2016. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 22:54 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,000 | $35.76 | $35,760.00 |
DisclosureSEC source: 0001209191-20-001334 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 22:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,922 | $64.00 | $123,008.00 |
DisclosureSEC source: 0001209191-19-060711 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,461 F1 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated March 1, 2019. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,000 | $62.00 | $124,000.00 |
DisclosureSEC source: 0001209191-19-057015 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,383 F1 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated March 1, 2019. F2 · balance_after: Includes 107 shares acquired under the Issuer's employee stock purchase plan in November 2019. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 23:49 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,000 | $60.00 | $120,000.00 |
DisclosureSEC source: 0001209191-19-056475 · doc4.xml · nonDerivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,276 F2 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated March 1, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:49 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option Plan · Derivative | 1,000 | $0.00 Strike: $42.57 | $0.00 |
DisclosureSEC source: 0001209191-19-056475 · doc4.xml · derivative · entry 6 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2020-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the April 29, 2013 date of grant until fully vested on April 29, 2016. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:49 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,000 | $58.00 | $116,000.00 |
DisclosureSEC source: 0001209191-19-056475 · doc4.xml · nonDerivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,276 F2 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated March 1, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:49 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 6,000 | $56.36 | $338,179.80 |
DisclosureSEC source: 0001209191-19-056475 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,276 F2 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated March 1, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.42 to $56.9434, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:49 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,000 | $57.83 | $57,830.00 |
DisclosureSEC source: 0001209191-19-056475 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,276 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 21, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:49 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,000 | $42.57 | $42,570.00 |
DisclosureSEC source: 0001209191-19-056475 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 5,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055093 · doc4.xml · nonDerivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,276 F4 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2019, until fully vested on 10/31/2022. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 3,869 | $42.11 | $162,923.59 |
DisclosureSEC source: 0001209191-19-055093 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,551 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 466 | $42.11 | $19,623.26 |
DisclosureSEC source: 0001209191-19-055093 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,420 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 892 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055093 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,886 F1 · shares: Reflects shares released on October 31, 2019 in connection with the vesting of performance-based market stock units granted on December 13, 2017. Includes 580 shares acquired under the Issuer's employee stock purchase plan in May 2019. Read SEC document |
| April 30, 2019 Filed May 2, 2019 00:16 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 514 | $37.67 | $19,362.38 |
DisclosureSEC source: 0001209191-19-026885 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,414 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001209191-19-020640 · doc4.xml · derivative · entry 6 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2019-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 10/31/12 date of grant until fully vested on 10/29/15. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,208 | $0.00 Strike: $31.73 | $0.00 |
DisclosureSEC source: 0001209191-19-020640 · doc4.xml · derivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,792 Underlying: Common Stock · 3,208 shares Expires 2020-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the 8/02/10 date of grant until fully vested on 8/02/14. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,109 | $0.00 Strike: $25.50 | $0.00 |
DisclosureSEC source: 0001209191-19-020640 · doc4.xml · derivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,109 shares Expires 2019-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the total number of shares subject to the option vested and became exercisable on the 12 month anniversary of the 7/27/09 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 27th day of each month thereafter until fully vested on 7/27/13. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 1,000 | $23.16 | $23,160.00 |
DisclosureSEC source: 0001209191-19-020640 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,208 | $31.73 | $101,789.84 |
DisclosureSEC source: 0001209191-19-020640 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 5,109 | $25.50 | $130,279.50 |
DisclosureSEC source: 0001209191-19-020640 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.